• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

延长组胺 H 受体驻留时间的途径:从地氯雷他定到鲁帕他定。

Route to Prolonged Residence Time at the Histamine H Receptor: Growing from Desloratadine to Rupatadine.

机构信息

Amsterdam Institute for Molecules, Medicines and Systems, Division of Medicinal Chemistry, Faculty of Science , VU University Amsterdam , De Boelelaan 1083 , 1081 HV Amsterdam , The Netherlands.

Operations, BioPharmaceuticals R&D , AstraZeneca , Alderley Park , Macclesfield SK10 4TG , United Kingdom.

出版信息

J Med Chem. 2019 Jul 25;62(14):6630-6644. doi: 10.1021/acs.jmedchem.9b00447. Epub 2019 Jul 5.

DOI:10.1021/acs.jmedchem.9b00447
PMID:31274307
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC6750840/
Abstract

Drug-target binding kinetics are an important predictor of in vivo drug efficacy, yet the relationship between ligand structures and their binding kinetics is often poorly understood. We show that both rupatadine () and desloratadine () have a long residence time at the histamine H receptor (HR). Through development of a [H]levocetirizine radiolabel, we find that the residence time of exceeds that of more than 10-fold. This was further explored with 22 synthesized rupatadine and desloratadine analogues. Methylene-linked cycloaliphatic or β-branched substitutions of desloratadine increase the residence time at the HR, conveying a longer duration of receptor antagonism. However, cycloaliphatic substituents directly attached to the piperidine amine (i.e., lacking the spacer) have decreased binding affinity and residence time compared to their methylene-linked structural analogues. Guided by docking studies, steric constraints within the binding pocket are hypothesized to explain the observed differences in affinity and binding kinetics between analogues.

摘要

药物-靶标结合动力学是体内药物疗效的一个重要预测指标,但配体结构与其结合动力学之间的关系往往知之甚少。我们表明,芦氯他定()和地氯雷他定()在组胺 H 受体(HR)上都具有较长的停留时间。通过开发[H]左西替利嗪放射性标记物,我们发现的停留时间超过了的停留时间 10 倍以上。这通过 22 种合成的芦氯他定和地氯雷他定类似物进一步进行了探索。地氯雷他定中环脂族亚甲基连接或 β-支链取代增加了在 HR 上的停留时间,从而延长了受体拮抗作用的持续时间。然而,与亚甲基连接的结构类似物相比,直接连接到哌啶胺的脂环取代基(即没有间隔物)的结合亲和力和停留时间降低。受对接研究的指导,假设结合口袋内的空间位阻可以解释类似物之间亲和力和结合动力学观察到的差异。

相似文献

1
Route to Prolonged Residence Time at the Histamine H Receptor: Growing from Desloratadine to Rupatadine.延长组胺 H 受体驻留时间的途径:从地氯雷他定到鲁帕他定。
J Med Chem. 2019 Jul 25;62(14):6630-6644. doi: 10.1021/acs.jmedchem.9b00447. Epub 2019 Jul 5.
2
Effects of Rupatadine on Platelet- Activating Factor-Induced Human Mast Cell Degranulation Compared With Desloratadine and Levocetirizine (The MASPAF Study).芦曲班特对血小板激活因子诱导的人肥大细胞脱颗粒作用的影响与地氯雷他定和左西替利嗪的比较(MASPAF 研究)。
J Investig Allergol Clin Immunol. 2017;27(3):161-168. doi: 10.18176/jiaci.0117. Epub 2016 Oct 19.
3
BRET-based β-arrestin2 recruitment to the histamine H1 receptor for investigating antihistamine binding kinetics.基于生物发光共振能量转移的β-抑制蛋白2募集至组胺H1受体以研究抗组胺药结合动力学
Pharmacol Res. 2016 Sep;111:679-687. doi: 10.1016/j.phrs.2016.07.034. Epub 2016 Jul 26.
4
Biochemical characterization of desloratadine, a potent antagonist of the human histamine H(1) receptor.地氯雷他定(一种强效的人组胺H(1)受体拮抗剂)的生化特性
Eur J Pharmacol. 2002 Aug 9;449(3):229-37. doi: 10.1016/s0014-2999(02)02049-6.
5
Comparative efficacy of bilastine, desloratadine and rupatadine in the suppression of wheal and flare response induced by intradermal histamine in healthy volunteers.比拉斯汀、地氯雷他定和卢帕他定对健康志愿者皮内注射组胺所致风团和潮红反应抑制作用的疗效比较
Curr Med Res Opin. 2017 Jan;33(1):129-136. doi: 10.1080/03007995.2016.1240665. Epub 2016 Oct 21.
6
Design, synthesis and biological activity evaluation of desloratadine analogues as H1 receptor antagonists.设计、合成及对作为 H1 受体拮抗剂的地氯雷他定类似物的生物活性评价。
Bioorg Med Chem. 2013 Jul 15;21(14):4178-85. doi: 10.1016/j.bmc.2013.05.004. Epub 2013 May 15.
7
Preclinical pharmacology of desloratadine, a selective and nonsedating histamine H1 receptor antagonist. 1st communication: receptor selectivity, antihistaminic activity, and antiallergenic effects.地氯雷他定的临床前药理学,一种选择性非镇静性组胺H1受体拮抗剂。首次通讯:受体选择性、抗组胺活性及抗过敏作用。
Arzneimittelforschung. 2000 Apr;50(4):345-52. doi: 10.1055/s-0031-1300213.
8
Rupatadine effectively prevents the histamine-induced up regulation of histamine H1R and bradykinin B2R receptor gene expression in the rat paw.芦帕他定能有效抑制组胺诱导的大鼠爪部组胺 H1R 和缓激肽 B2R 受体基因表达的上调。
Pharmacol Rep. 2014 Dec;66(6):952-5. doi: 10.1016/j.pharep.2014.06.008. Epub 2014 Jun 21.
9
Desloratadine inhibits constitutive and histamine-stimulated nuclear factor-kappaB activity consistent with inverse agonism at the histamine H1 Receptor.地氯雷他定抑制组成性和组胺刺激的核因子-κB活性,这与它在组胺H1受体上的反向激动作用一致。
Int Arch Allergy Immunol. 2004 Dec;135(4):313-8. doi: 10.1159/000082325. Epub 2004 Nov 24.
10
Simultaneous determination of rupatadine and its metabolite desloratadine in human plasma by a sensitive LC-MS/MS method: application to the pharmacokinetic study in healthy Chinese volunteers.采用灵敏的液相色谱-串联质谱法同时测定人血浆中卢帕他定及其代谢物地氯雷他定:在健康中国志愿者中的药代动力学研究应用
J Pharm Biomed Anal. 2009 Feb 20;49(2):347-53. doi: 10.1016/j.jpba.2008.10.014. Epub 2008 Nov 1.

引用本文的文献

1
Design and synthesis of photoswitchable desloratadine ligands for histamine H receptor photopharmacology.用于组胺H受体光药理学的光开关地氯雷他定配体的设计与合成。
RSC Med Chem. 2025 Aug 13. doi: 10.1039/d5md00589b.
2
Residence time in drug discovery: current insights and future perspectives.药物研发中的驻留时间:当前见解与未来展望。
Pharmacol Rep. 2025 Jun 9. doi: 10.1007/s43440-025-00748-z.
3
Optimization of Peptide Linker-Based Fluorescent Ligands for the Histamine H Receptor.基于肽键的荧光配体对组胺 H 受体的优化。

本文引用的文献

1
Probe dependency in the determination of ligand binding kinetics at a prototypical G protein-coupled receptor.探究在典型 G 蛋白偶联受体中确定配体结合动力学的探针依赖性。
Sci Rep. 2019 May 27;9(1):7906. doi: 10.1038/s41598-019-44025-5.
2
Design, synthesis and bioevaluation of tricyclic fused ring system as dual binding site acetylcholinesterase inhibitors.三环稠合环系统作为双结合位点乙酰胆碱酯酶抑制剂的设计、合成与生物评价。
Bioorg Chem. 2019 Mar;83:336-347. doi: 10.1016/j.bioorg.2018.10.035. Epub 2018 Oct 23.
3
The Target Residence Time of Antihistamines Determines Their Antagonism of the G Protein-Coupled Histamine H1 Receptor.
J Med Chem. 2022 Jun 23;65(12):8258-8288. doi: 10.1021/acs.jmedchem.2c00125. Epub 2022 Jun 3.
4
Decisive role of water and protein dynamics in residence time of p38α MAP kinase inhibitors.水和蛋白质动力学在 p38α MAP 激酶抑制剂停留时间中的决定性作用。
Nat Commun. 2022 Jan 28;13(1):569. doi: 10.1038/s41467-022-28164-4.
5
Exploring the Effect of Cyclization of Histamine H Receptor Antagonists on Ligand Binding Kinetics.探究组胺H受体拮抗剂环化对配体结合动力学的影响。
ACS Omega. 2021 May 7;6(19):12755-12768. doi: 10.1021/acsomega.0c06358. eCollection 2021 May 18.
6
Molecular Modeling of Histamine Receptors-Recent Advances in Drug Discovery.组胺受体的分子建模-药物发现的最新进展。
Molecules. 2021 Mar 22;26(6):1778. doi: 10.3390/molecules26061778.
7
Molecular Determinants of the Kinetic Binding Properties of Antihistamines at the Histamine H Receptors.组胺 H 受体上抗组胺药动力学结合特性的分子决定因素。
Int J Mol Sci. 2021 Feb 27;22(5):2400. doi: 10.3390/ijms22052400.
8
Perspective: Implications of Ligand-Receptor Binding Kinetics for Therapeutic Targeting of G Protein-Coupled Receptors.观点:配体-受体结合动力学对G蛋白偶联受体治疗靶点的影响
ACS Pharmacol Transl Sci. 2020 Mar 18;3(2):179-189. doi: 10.1021/acsptsci.0c00012. eCollection 2020 Apr 10.
9
A general carbonyl alkylative amination for tertiary amine synthesis.一种通用的羰基烷基化胺化反应用于叔胺合成。
Nature. 2020 May;581(7809):415-420. doi: 10.1038/s41586-020-2213-0. Epub 2020 Apr 8.
抗组胺药的目标停留时间决定了它们对G蛋白偶联组胺H1受体的拮抗作用。
Front Pharmacol. 2017 Sep 25;8:667. doi: 10.3389/fphar.2017.00667. eCollection 2017.
4
Drug target residence time: a misleading concept.药物靶点停留时间:一个误导性概念。
Drug Discov Today. 2018 Jan;23(1):12-16. doi: 10.1016/j.drudis.2017.07.016. Epub 2017 Aug 3.
5
The influence of drug distribution and drug-target binding on target occupancy: The rate-limiting step approximation.药物分布和药物-靶点结合对靶点占有率的影响:限速步骤近似。
Eur J Pharm Sci. 2017 Nov 15;109S:S83-S89. doi: 10.1016/j.ejps.2017.05.024. Epub 2017 May 12.
6
A comprehensive map of molecular drug targets.分子药物靶点综合图谱。
Nat Rev Drug Discov. 2017 Jan;16(1):19-34. doi: 10.1038/nrd.2016.230. Epub 2016 Dec 2.
7
Identification of Ligand Binding Hot Spots of the Histamine H Receptor following Structure-Based Fragment Optimization.基于结构的片段优化后组胺H受体配体结合热点的鉴定
J Med Chem. 2016 Oct 13;59(19):9047-9061. doi: 10.1021/acs.jmedchem.6b00981. Epub 2016 Sep 27.
8
BRET-based β-arrestin2 recruitment to the histamine H1 receptor for investigating antihistamine binding kinetics.基于生物发光共振能量转移的β-抑制蛋白2募集至组胺H1受体以研究抗组胺药结合动力学
Pharmacol Res. 2016 Sep;111:679-687. doi: 10.1016/j.phrs.2016.07.034. Epub 2016 Jul 26.
9
In vivo Target Residence Time and Kinetic Selectivity: The Association Rate Constant as Determinant.体内靶标停留时间和动力学选择性:结合速率常数作为决定因素。
Trends Pharmacol Sci. 2016 Oct;37(10):831-842. doi: 10.1016/j.tips.2016.06.008. Epub 2016 Jul 6.
10
Effects of target binding kinetics on in vivo drug efficacy: koff , kon and rebinding.靶点结合动力学对体内药物疗效的影响:解离速率常数、结合速率常数与再结合
Br J Pharmacol. 2016 Aug;173(15):2319-34. doi: 10.1111/bph.13504. Epub 2016 Jul 4.